{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-NMJIU4KG/32d725a7-2399-4446-8343-126c8957fae1/PDF","dcterms:extent":"1487 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-NMJIU4KG/c3b3e74b-af9e-430c-bbb7-cb4692b04409/TEXT","dcterms:extent":"37 KB"}],"edm:TimeSpan":{"@rdf:about":"1929-2026","edm:begin":{"@xml:lang":"en","#text":"1929"},"edm:end":{"@xml:lang":"en","#text":"2026"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:DOC-NMJIU4KG","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp"},{"@xml:lang":"sl","#text":"Zdravniški vestnik"}],"dcterms:issued":"2023","dc:creator":["Janić, Miodrag","Lunder, Mojca","Pučnik, Tina"],"dc:format":[{"@xml:lang":"sl","#text":"številka:11/12"},{"@xml:lang":"sl","#text":"letnik:92"},{"@xml:lang":"sl","#text":"str. 468-475"}],"dc:identifier":["DOI:10.6016/ZdravVestn.3457","ISSN:1318-0347","COBISSID:183926531","URN:URN:NBN:SI:doc-NMJIU4KG"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"dc:subject":[{"@xml:lang":"sl","#text":"dapagliflozin"},{"@xml:lang":"en","#text":"diabetic ketoacidosis"},{"@xml:lang":"sl","#text":"diabetična ketoacidoza"},{"@xml:lang":"sl","#text":"empagliflozin"},{"@xml:lang":"en","#text":"risk factors"},{"@xml:lang":"en","#text":"SGLT-2 inhibitors"},{"@xml:lang":"sl","#text":"sprožilni dejavniki"},{"@xml:lang":"sl","#text":"zaviralci SGLT-2"}],"dcterms:temporal":{"@rdf:resource":"1929-2026"},"dc:title":{"@xml:lang":"sl","#text":"Diabetična ketoacidoza| redek, a resen zaplet zdravljenja z zaviralci SGLT-2 – pregled literature in prikaz serije primerov| Diabetic ketoacidosis| a rare but serious complication of treatment with SGLT-2 inhibitors – literature review and case series presentation|"},"dc:description":{"@xml:lang":"sl","#text":"Zdravniški vestnik je strokovno glasilo slovenskega zdravništva, ki ga izdaja Slovensko zdravniško društvo. Revija izhaja od leta 1992 in nadaljuje delo svojega predhodnika Zdravstvenega vestnika. Zdravniški vestnik izhaja mesečno in je na voljo tudi v spletni obliki"},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:DOC-NMJIU4KG","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:DOC-NMJIU4KG"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:DOC-NMJIU4KG/32d725a7-2399-4446-8343-126c8957fae1/PDF"},"edm:rights":{"@rdf:resource":"http://creativecommons.org/licenses/by-nc/4.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:DOC-NMJIU4KG/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:DOC-NMJIU4KG"}}}}